Announcement for �Innovation for Cool Earth Forum 9th Annual Meeting (ICEF2022)�

2 years ago

The international conference to discuss innovation, the key to solving global warming with experts from industry, academia, and government from…

Cellusion and Celregen, a member of Fosun Pharma, Enter into Exclusive License Agreement of CLS001 for a Corneal Endothelial Cell Regenerative Therapy in the Greater China Region

2 years ago

Celregen Obtains the Exclusive Rights to Develop, Manufacturing and Commercialize CLS001 in Greater China Region; Cellusion Retains Other Regional Rights.…

Shin Kong Financial Holdings selects DataRobot�s AI Cloud Platform to implement its AI and Data democratization strategies & drive digital transformation goals

2 years ago

TAIPEI, TAIWAN - Media OutReach - 12 September 2022 - As the wave of new digital technologies continues to sweep…

Movie + NFT, a New Entertainment Paradigm Jointly Offered by TXPC (Shanghai) Network Technologies and Art Tokyo Global

2 years ago

SHANGHAI/SINGAPORE - Media OutReach - 12 September 2022 - TXPC (Shanghai) Network Technologies Co., Ltd ("TXPC") and the Singapore-based company,…

BeaRex To Hold a 10,000 USDT Giveaway in Honor of Its Beta Game Launch on Web and Telegram

2 years ago

DUBAI, UAE - Media OutReach - 12 September 2022 - BeaRex, a vibrant blockchain runner that has combined GameFi's Free2Play…

Base Business Solutions and Uniphore Partner to Bring Emerging Technology to Vietnam�s CX Industry

2 years ago

The partnership will help boost contact center employee morale and provide superior customer experiences using Conversational AI and Automation HO…

Square Enix Joins Oasys Gaming Blockchain, To Explore Development of New Blockchain Games

2 years ago

SINGAPORE - Media OutReach - 12 September 2022 - Oasys, an environmentally-friendly, gaming-optimised Proof-of-Stake blockchain built for gamers by gamers,…

Chery Is Accompanied With Love at the Mid-Autumn Festival

2 years ago

WUHU, China--(BUSINESS WIRE)--China celebrates the Mid-Autumn Festival on September 10. On this day, all Chinese families will partake in eating…

ENHERTU� Continues to Demonstrate Clinically Meaningful Tumor Response in Patients with HER2 Mutant Metastatic Non-Small Cell Lung Cancer

2 years ago

DESTINY-Lung02 phase 2 trial shows clinically meaningful efficacy and favorable safety at 5.4 mg/kg dose versus 6.4 mg/kg dose of…

DS-7300 Continues to Show Promising Durable Response in Patients with Several Types of Advanced Cancer

2 years ago

Extended follow-up data from phase 1/2 trial of DS-7300 in patients with metastatic lung, prostate or esophageal cancer to be…